Similarly, the HLA-DR53-restricted, STEAP281-296-reactive CD4 T-cell clones, SH6, HK7 and Sa12 recognized STEAP+/DR53+ LC tumors (LU65, Calu-1, Figure 6B, C and 6D). This evidence concerns the gene CALU and laryngotracheoesophageal cleft.